Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Share-based Compensation (2020 - 2026)

Updated

Century Therapeutics (IPSC) posted Share-based Compensation of $1.95 million for Q2 2026, down 12.2% from $2.22 million a year earlier but up 34.9% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Share-based Compensation (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Century Therapeutics was $5.59 million, down 47.4% year-over-year; for FY2025, it came in at $6.84 million, down 46.1% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 50.8% (FY2020 to FY2025).
  • In prior years, Century Therapeutics' Share-based Compensation was $12.69 million in FY2024 (-13.2%), $14.62 million in FY2023 (+37.1%), $10.67 million in FY2022 (+128.9%) and $4.66 million in FY2021 (+432.2%).
  • Quarterly Share-based Compensation has run from a low of $892,000 in Q3 2025 to a high of $3.98 million in Q3 2023 over five years.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last eight quarters, with an average decline of 35.0% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 747.2%; the weakest was Q3 2025, with a decline of 73.1%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $1.45 million (Q1 2026), $1.3 million (Q4 2025) and $892,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Century Therapeutics 301.51 Mn -202.86 Mn - 1.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.95 Mn
Mar 31, 2026 1.45 Mn
Dec 31, 2025 1.30 Mn
Sep 30, 2025 892,000.00
Jun 30, 2025 2.22 Mn
Mar 31, 2025 2.43 Mn
Dec 31, 2024 2.66 Mn
Sep 30, 2024 3.32 Mn
Jun 30, 2024 3.50 Mn
Mar 31, 2024 3.21 Mn
Dec 31, 2023 3.56 Mn
Sep 30, 2023 3.98 Mn
Jun 30, 2023 3.29 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 2.73 Mn
Sep 30, 2022 2.79 Mn
Jun 30, 2022 2.77 Mn
Mar 31, 2022 2.38 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 1.22 Mn
API Access

Century Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IPSC&period=max&api_key=YOUR_API_KEY